Price T Rowe Associates Inc Cardlytics, Inc. Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Cardlytics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 62,471 shares of CDLX stock, worth $222,396. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,471
Previous 39,274
59.06%
Holding current value
$222,396
Previous $126,000
84.13%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CDLX
# of Institutions
122Shares Held
30.4MCall Options Held
509KPut Options Held
263K-
Cliff Sosin Cas Investment Partners, LLC | New York, Ny6.37MShares$22.7 Million1.38% of portfolio
-
Black Rock Inc. New York, NY3.15MShares$11.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$9.58 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY1.31MShares$4.66 Million0.35% of portfolio
-
Kps Global Asset Management Uk LTD London, X01.22MShares$4.34 Million0.92% of portfolio
About Cardlytics, Inc.
- Ticker CDLX
- Exchange NASDAQ
- Sector Communication Services
- Industry Advertising Agencies
- Shares Outstandng 32,893,800
- Market Cap $117M
- Description
- Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...